Johnson & Johnson (NYSE:JNJ) outlined its commercialization plans for the OTTAVA robotic surgical system after receiving U.S. Food and Drug Administration De Novo authorization, positioning the ...
Rocco De Bernardis, global president for Ottava, gets into the details of what makes the new robotic surgery system different ...
The Society of Robotic Surgery Annual Meeting (SRS 2026) took place over a few days last week in Hollywood, Florida.
A Giant Leap for Surgical Robots In what could mark a turning point for medicine, an autonomous robot has managed to perform ...
The FDA grants marketing authorization for Johnson & Johnson’s Ottava robotic surgery system for upper abdominal procedures.
2d
SS Innovations International (SSII) Expands Global Footprint on Fast-Growing Robotic Surgery Market
The company is expanding its presence in the global surgical robotics market through its proprietary SSi Mantra robotic surgery platform. The company's strategy combines world-class robotic systems, ...
Vinmec Times City International Hospital serves as the clinical coordination hub, linking robotic surgery centers at Vinmec ...
Johnson & Johnson announced today that it received FDA de novo authorization for its Ottava surgical robot system.
Johnson & Johnson MedTech unveiled its long-awaited Ottava surgical robot after winning FDA de novo authorization. It’s the ...
SS Innovations International (NASDAQ: SSII), a developer of innovative surgical robotic technologies, will bring its ...
Bangkok Hospital Headquarters is strengthening the expertise of its surgical teams to provide better robot-assisted surgery ...
Robotic surgery used to be fodder for science fiction movies. Not anymore. They are becoming more mainstream by the day. While fully autonomous surgeries in the medical sector are not yet a reality, ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results